Senior Manager, New Product Planning - Oncology

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn.

The Sr. Manager / Associate Director of New Product Planning (NPP) – Oncology reports to the head of New Products Planning and plays a critical strategic role at the interface of R&D and Commercial. This leader provides deep market insights, competitive intelligence, and strategic commercial guidance to shape the development of early‑stage and mid‑stage oncology assets, with a particular focus on U.S. markets. The role ensures pipeline programs are positioned for clinical, regulatory, and commercial success, while helping the organization make informed investment and portfolio decisions.

Job Duties and Responsibilities

• Lead commercial strategy for all global oncology pipeline programs, partnering closely with R&D to shape Target Product Profiles and development plans.
• Develop and assess market landscapes, including patient segments, treatment paradigms, and competitive pipelines, to inform asset and portfolio decisions.
• Develop commercial forecasts and scenario analysis to support valuation, prioritization, and investment cases.
• Provide strategic input on clinical trial design, evidence generation, and regulatory strategy to optimize future market access and differentiation.
• Generate insights from competitive intelligence, market research, and external expertise to guide strategic recommendations.
• Support annual portfolio prioritization process by providing an objective commercial perspective on global R&D oncology programs. 
• Collaborate cross‑functionally across Clinical, Regulatory, Medical, HEOR, and Finance to integrate commercial perspectives into drug development.
• Support early brand development, including value propositions, positioning concepts, and go‑to‑market considerations.
• Contribute to business development assessments with commercial evaluations of external assets.

Key Core Competencies

• Deep understanding of oncology therapeutic areas, clinical development pathways, and payer/reimbursement considerations.
• Demonstrated expertise developing detailed financial forecasts, TPPs and market opportunity assessments.
• Ability to develop relationships in the organization, active listening and influencing are strongly preferred.
• Ability to work across multiple geographies.
• Strong strategic thinking and structured problem‑solving skills.
• Proven ability to translate data and scientific insights into actionable recommendations.
• Excellent communication, presentation, and storytelling abilities.
• Comfortable operating in ambiguity, fast‑paced environments, and matrixed organizations.

Education and Experience

• Bachelor’s degree required; Master’s degree preferred.
• Minimum 8 – 12 (w/o Master’s) or 6 – 8 years (with Master’s) of relevant experience in biotech or pharmaceutical industry
• Prior experience in commercial planning, new product planning, or related strategic roles within biotechnology/pharmaceutical companies and/or consulting.
• Therapeutic Area: Experience in oncology (solid tumor and heme malignancies) is strongly preferred.

The base salary range for this role is $162,700 to $203,400. Base salary is part of our total rewards package which also includes the opportunity for merit-based salary increases, short incentive plan participation, eligibility for our 401(k) plan, medical, dental, vision, life and disability insurances and leaves provided in line with your work state. Our robust time-off policy includes flexible paid time off, 11 paid holidays plus additional time off for a shut-down period during the l